MustGrow Conducts Successful Proof Of Concept For Mustard Derived Bio-Herbicide

MustGrow Biologics (CSE: MGRO) has successfully completed a proof-of-concept for its proprietary biological non-selective bio-herbicide. The company announced this morning that its signature mustard-derived formulation has passed this proof of concept for the control of wanted pests and diseases.

The proof of concept conducted by the company demonstrated that its formulation has successfully shown that it kills 100% of weeds when applied on small weeds and weed seeds. The bio-herbicide was found to kill the target plants from the root up, while potentially showing control of the weed seeds themselves. The proof of concept as a result confirmed previously conducted third-party trials.

The successful proof of concept validates the firms natural approach to controlling unwanted pests and diseases. The proprietary formula, which utilizes the natural defence mechanism within mustard seed, has now proven itself as both a bio-pesticide and a bio-herbicide. The company is now in the process of conducting larger trials to reconfirm efficacy, application rates and overall length of control. These trials are expected to be completed by the end of the year.

“The developing characteristics of our active ingredient as a non-selective bio-herbicide represent a key application of our remarkable natural mustard-based technology. We are excited to potentially provide a natural solution for not only farmers but for home and garden use as well.”

Corey Giasson, CEO of MustGrow Biologics

The global herbicides market is currently estimated at over $24.6 billion as of 2018, while expected to grow by $8.9 billion through to 2023. This market was also the dominant crop protection category, accounting for approximately 42.7% of all crop protection sales in 2018.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

MustGrow Biologics last traded at $0.38 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM

MustGrow Sees Positive Results From Tobacco Field Trials

MustGrow Biologics (CSE: MGRO) this morning reported on results for the use of its mustard-based...

Monday, April 12, 2021, 08:16:06 AM

MustGrow Biologics Sees CannaPM Approved For Use Against Powdery Mildew In Cannabis And Hemp

It appears that revenues might be coming in the near term to MustGrow Biologics (CSE:...

Wednesday, February 24, 2021, 07:11:49 AM

MustGrow: Seasoned Social Impact Financier Barry Palte Appointed To Advisory Board

MustGrow Biologics (CSE: MGRO) this morning announced that it has strengthened its advisory team. The...

Thursday, September 17, 2020, 08:38:56 AM

MustGrow Biologics: NexusBioAg Partnership Validates Firms Research Program

Among current trends, governments around the world are banning the use of harmful pesticides and...

Monday, May 24, 2021, 02:16:00 PM